Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-12-000354
Filing Date
2012-02-16
Accepted
2012-02-16 15:02:44
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 JINZANGHUANG TIBET PHARMACEUTICALS, INC. 10Q 2011-12-31 jinzanghuang10q.htm 10-Q 432883
2 RULE 13A-14(A) CERTIFICATION ? CEO jinzanghuangexh311.htm EX-31.1 10561
3 RULE 13A-14(A) CERTIFICATION ? CFO jinzanghuangexh312.htm EX-31.2 10322
4 RULE 13A-14(B) CERTIFICATION jinzanghuangexh32.htm EX-32 7099
  Complete submission text file 0001096906-12-000354.txt   1329704

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE jzhg-20111231.xml EX-101.INS 105705
6 XBRL SCHEMA jzhg-20111231.xsd EX-101.SCH 8352
7 XBRL CALCULATION jzhg-20111231_cal.xml EX-101.CAL 4766
8 XBRL DEFINITION jzhg-20111231_def.xml EX-101.DEF 42032
9 XBRL LABEL jzhg-20111231_lab.xml EX-101.LAB 75823
10 XBRL PRESENTATION jzhg-20111231_pre.xml EX-101.PRE 54203
Mailing Address HARBORSIDE FINANCIAL CENTER 2500 PLAZA V JERSEY CITY NJ 07311
Business Address HARBORSIDE FINANCIAL CENTER 2500 PLAZA V JERSEY CITY NJ 07311 201-882-3332
JINZANGHUANG TIBET PHARMACEUTICALS, INC. (Filer) CIK: 0000910832 (see all company filings)

EIN.: 262443288 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-53254 | Film No.: 12619108
SIC: 6770 Blank Checks